Bursa Malaysia Uplifts Pharmaniaga From PN17 Status Effective Tomorrow
KUALA LUMPUR, March 16 (Bernama) -- Bursa Malaysia said Pharmaniaga Bhd will be uplifted from its PN17 status effective 9 am tomorrow.
There are 86 news based on search keyword " pharmaceutical "
Fortrea Expands Executive Team For Clinical Development, Deepens Client Partnerships
KUALA LUMPUR, Feb 23 (Bernama) -- Fortrea, a global contract research organisation (CRO), has strengthened its executive leadership with Oren Cohen and Scott Dove.
Helus Pharma Names Michael Cola As CEO For Next Phase Of Growth
KUALA LUMPUR, Feb 11 (Bernama) -- Helus Pharma (Helus), a clinical-stage pharmaceutical company, has appointed Michael Cola as its Chief Executive Officer (CEO) effective immediately, as the company enters its next phase of scale and execution.
Carterra Launches High-Throughput SPR Platform For Faster Biomolecular Screening
KUALA LUMPUR, Feb 10 (Bernama) -- Carterra Inc, a provider of innovative technologies designed to accelerate the discovery of novel therapeutic candidates, has launched its Carterra Vega High-Throughput Surface Plasmon Resonance (HT-SPR) instrument, the industry’s first 48-channel SPR platform.
SME Sector Seen As Key In Expanding Malaysia-India Economic Ties
KUALA LUMPUR, Jan 28 (Bernama) -- Small and medium enterprises (SMEs) should be a key focus in efforts to deepen Malaysia-India economic ties, as India offers vast market opportunities for Malaysian businesses seeking to expand overseas, said ASEAN-India Economic Council chairman Datuk Ramesh Kodammal.
Angelini Pharma Appoints Sergio Marullo di Condojanni As CEO
KUALA LUMPUR, Jan 22 (Bernama) -- Angelini Pharma, part of the multinational privately owned industrial group Angelini Industries, has appointed Sergio Marullo di Condojanni as Chief Executive Officer (CEO).
JcbNext Disposes Of 9.45 Pct Remaining Stake In Nova Pharma For RM5.21 Mln
KUALA LUMPUR, Jan 19 (Bernama) -- JcbNext Bhd has disposed of its entire 9.45 per cent equity interest in Nova Pharma Solutions Bhd for RM5.21 million after accepting an unconditional mandatory takeover offer from Southern Score Builders Bhd.
Trump Tariffs In Focus Ahead Of Key US Court Decision
KUALA LUMPUR, Jan 14 (Bernama) -- Countries across the globe, including Malaysia, await the US Supreme Court ruling later today on the reciprocal tariff imposed by President Donald Trump.
Helus Pharma Rebrands, Debuts On Nasdaq
KUALA LUMPUR, Jan 6 (Bernama) -- Helus Pharma, formerly Cybin Inc, marked its transition toward commercialisation as it began trading on the Nasdaq Global Market and Cboe Canada under the ticker symbol HELP, reflecting a strategic rebrand and corporate repositioning.
13MP, VM2026, Stronger Ringgit To Support Market In 1Q 2026 -- Malacca Securities
KUALA LUMPUR, Jan 2 (Bernama) -- Domestic catalysts, particularly the 13th Malaysia Plan (13MP), Visit Malaysia 2026 (VM2026) and a strengthening ringgit environment, are expected to drive the market performance in the first quarter (1Q) of 2026.
2025 Tax Trinity: US Tariffs, SST Expansion and E-invoicing
KUALA LUMPUR, Dec 11 (Bernama) -- 2025 will be remembered as the “tariff year”, no thanks to the unexpected United States (US) tariffs that shook markets worldwide, with Malaysia not spared.
N. Sembilan Actively Developing New Industrial Areas To Drive Quality Investment - Exco
SEREMBAN, Dec 10 (Bernama) -- The Negeri Sembilan government is capable of attracting quality, high-impact investments, particularly in the electrical and electronics, semiconductor, aerospace, food technology and pharmaceutical sectors - all of which align with the targeted clusters under the Central Region industrial development plan.